IBEX Limited (IBEX) Q4 FY2026 earnings

Reported results

• Q4 revenue of $164.3 million increased 11.6% from $147.1 million in prior year quarter; full-year revenue of $644.1 million increased 15.4% from $558.3 million
• Full-year net income of $46.3 million increased 25.7% from $36.9 million; full-year diluted EPS of $3.13 increased 32.8% from $2.36
• Full-year non-GAAP adjusted net income of $52.2 million increased 21.3% from $43.0 million; full-year non-GAAP adjusted EPS of $3.52 increased 28.3% from $2.75
• Full-year adjusted EBITDA of $82.4 million increased 14.5% from $72.0 million; adjusted EBITDA margin of 12.8% compared to 12.9% in prior year
• Q4 operating cash flow of $24.8 million and free cash flow of $21.7 million; full-year operating cash flow of $59.0 million and free cash flow of $31.2 million, up from $27.3 million
• Net cash of $30.9 million as of June 30, 2026, an improvement of $17.2 million from $13.7 million as of June 30, 2025

Guidance

• Fiscal year 2027 revenue expected in range of $700 to $715 million, representing 9-11% growth
• Fiscal year 2027 non-GAAP adjusted EBITDA expected in range of $90 to $94 million, representing 9-14% growth
• First quarter fiscal 2027 revenue expected in range of $168 to $170 million, representing 11-12% growth
• First quarter fiscal 2027 non-GAAP adjusted EBITDA expected in range of $22 to $23 million, representing 13-18% growth
• Capital expenditures for fiscal year 2027 expected in range of $25 to $30 million

Notes

Company presented both GAAP and non-GAAP measures throughout the release. Non-GAAP reconciliations provided in Exhibits 1-4. Company noted inability to provide quantitative reconciliation of forward-looking adjusted EBITDA due to uncertainty in predicting stock-based compensation, foreign currency gains/losses, and non-recurring expenses.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-09-10 (8-K, Item 2.02). Read the original filing on sec.gov.